ESCRS - ESCRS Clinical Trends Survey 2019 Results
ESCRS - ESCRS Clinical Trends Survey 2019 Results
Supplements

ESCRS Clinical Trends Survey 2019 Results

ESCRS Clinical Trends Survey 2019 Results
Colin Kerr
Colin Kerr
Published: Thursday, November 5, 2020

This report contains the results of the 2019 ESCRS Clinical Trends Survey, conducted at the 37th ESCRS Congress in Paris, France. Delegates also had the option of taking the survey online at the ESCRS website. Questions addressed several areas of clinical practice, including general cataract surgery, astigmatism and toric IOLs, presbyopia correction, glaucoma and ocular surface disease. More than 2,100 doctors responded to 156 questions, which were developed and reviewed with the ESCRS leadership and substantiated by a data scientist. The survey results help ESCRS to better identify the educational needs of its members and the ESCRS leadership continually refers to the results of the annual surveys and the feedback they elicit. The collected data also enhances the education featured at the ESCRS Annual Congress, the ESCRS Winter Meeting and other educational channels, such as EuroTimes articles and online forums. We invite you to study the survey’s key findings and be ready to take advantage of upcoming educational events. ESCRS encourages all delegates to participate in the 2020 ESCRS Clinical Trends Survey here.

Latest Articles
Here Come the Robots

Robotic surgery applications in ophthalmology are expanding. Dermot McGrath reports from Paris.

Read more...

Optimising Long-Term Visual Outcomes for Patients with Neovascular AMD

High compliance of at-home monitoring with AI PHP system. Cheryl Guttman Krader reports from ARVO 2022.

Read more...

Non-Diffractive EDOF IOLs Gaining Ground

Distance and intermediate vision improve with less glare and halos than diffractive alternatives. Howard Larkin reports from the 2022 ASCRS Annual Meeting.

Read more...

Dexamethasone Intracanalicular Insert for Episodic DED

Early clinical trial results suggest 2–3 weeks of sustained and tapering corticosteroid therapy possible. Howard Larkin reports from the 2022 ASCRS Annual Meeting.

Read more...